Reports: FDA approves gel version of Merz's Naftin

Cream version of athlete's foot drug already approved

NEW YORK — The Food and Drug Administration has approved a gel formulation of a foot fungus drug made by Merz Pharmaceuticals, according to published reports.

According to reports, the FDA approved a gel formulation of Merz's Naftin (naftifine), used to treat athlete's foot, known medically as tinea pedis.

A cream version of the drug is already approved, and the latest approval was based on two clinical trials of more than 1,700 patients, according to reports.

 

Login or Register to post a comment.